Johnson & Johnson (JNJ): Price and Financial Metrics

JNJ POWR Grades

• JNJ scores best on the Stability dimension, with a Stability rank ahead of 96.58% of US stocks.
• JNJ's strongest trending metric is Growth; it's been moving up over the last 179 days.
• JNJ ranks lowest in Momentum; there it ranks in the 17th percentile.

JNJ Stock Summary

• With a market capitalization of $429,029,575,266, JOHNSON & JOHNSON has a greater market value than 99.84% of US stocks.
• JNJ's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 3,351.5 -- higher than 99.22% of US-listed equities with positive expected earnings growth.
• The volatility of JOHNSON & JOHNSON's share price is greater than that of just 0.8% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to JNJ, based on their financial statements, market capitalization, and price volatility, are XOM, TSM, V, UNH, and WMT.
• JNJ's SEC filings can be seen here. And to visit JOHNSON & JOHNSON's official web site, go to www.jnj.com.

JNJ Valuation Summary

• JNJ's price/sales ratio is 4.5; this is 104.55% higher than that of the median Healthcare stock.
• Over the past 243 months, JNJ's price/earnings ratio has gone down 5.3.

Below are key valuation metrics over time for JNJ.

JNJ Growth Metrics

Its year over year cash and equivalents growth rate is now at -17.43%.
• Its 5 year net cashflow from operations growth rate is now at 35.1%.
• The 4 year net cashflow from operations growth rate now stands at 35.1%.

JNJ's revenue has moved up $11,374,000,000 over the prior 15 months.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	95,588	23,582	18,366
2022-03-31	94,880	23,315	19,830
2021-12-31	93,775	23,410	20,878
2021-09-30	91,446	26,021	17,880
2021-06-30	89,190	26,114	17,767
2021-03-31	84,214	24,252	15,115

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• JNJ has a Quality Grade of B, ranking ahead of 92.45% of graded US stocks.
• JNJ's asset turnover comes in at 0.52 -- ranking 78th of 682 Pharmaceutical Products stocks.
• CBIO, CLSD, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.